Tvardi Therapeutics (TVRD) Assets (2013 - 2026)
Tvardi Therapeutics (TVRD) posted Assets of $25.8 million for Q1 2026, down 19.51% sequentially from $32.1 million in Q4 2025, and down 33.71% YoY from $38.9 million in Q1 2025.
Tvardi Therapeutics (TVRD) Assets (2013 - 2026) Analysis & Trends
Tvardi Therapeutics has reported Assets for 14 years, with the latest figure at $25.8 million in Q1 2026.
- Quarterly Assets fell 33.71% year-over-year to $25.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.8 million (down 33.71% YoY) and the FY2025 annual result came in at $32.1 million, down 8.88% from the prior year.
- Assets eased to $25.8 million in Q1 2026 per TVRD's latest filing, from $32.1 million in the prior quarter.
- Over five years, Assets peaked at $226.6 million in Q2 2022 and troughed at $25.8 million in Q1 2026.
- A 5-year average of $106.1 million and a median of $90.1 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2024: Assets increased 2.31% in 2022, then sank 72.03% in 2024.
- Over 5 years, Assets stood at $182.2 million in 2022, then slumped by 30.94% to $125.8 million in 2023, then tumbled by 72.03% to $35.2 million in 2024, then retreated by 8.88% to $32.1 million in 2025, then declined by 19.51% to $25.8 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $25.8 million, $32.1 million, and $39.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Tvardi Therapeutics | 17.36 Mn | 17.36 Mn | - | 17.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.82 Mn |
| Dec 31, 2025 | 32.07 Mn |
| Sep 30, 2025 | 39.02 Mn |
| Jun 30, 2025 | 43.75 Mn |
| Mar 31, 2025 | 38.95 Mn |
| Dec 31, 2024 | 35.20 Mn |
| Sep 30, 2024 | 51.33 Mn |
| Jun 30, 2024 | 72.50 Mn |
| Mar 31, 2024 | 90.10 Mn |
| Dec 31, 2023 | 125.84 Mn |
| Sep 30, 2023 | 115.34 Mn |
| Jun 30, 2023 | 134.39 Mn |
| Mar 31, 2023 | 153.28 Mn |
| Dec 31, 2022 | 182.24 Mn |
| Sep 30, 2022 | 213.51 Mn |
| Jun 30, 2022 | 226.57 Mn |
| Mar 31, 2022 | 223.87 Mn |
| Dec 31, 2021 | 247.06 Mn |
| Sep 30, 2021 | 225.09 Mn |
| Jun 30, 2021 | 221.45 Mn |